Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor page update. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows a recruitment status update indicating the study is no longer enrolling. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and a formatting change to the Intervention/Treatment heading plus a revision tag update (v3.6.0) were applied.SummaryDifference0.5%

- Check26 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, reflecting a small internal update to the page record without changes to the study content.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study status is updated to Completed, and new dates/metadata were added (Study Completion Actual: 2023-04-26; latest updates: 2026-05-11 and 2026-05-13; Revision: v3.5.4).SummaryDifference0.5%

- Check62 days agoChange Detected- Revision: v3.5.3 supersedes v3.5.2, indicating a minor administrative update to the study record on ClinicalTrials.gov. - The update does not change any study details or user-visible content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.